Journal: Experimental and Therapeutic Medicine

Article Title: Diospyros lotus leaf extract and its main component, myricitrin, inhibit both histamine‑dependent and histamine‑independent itching

doi: 10.3892/etm.2025.12871

Figure Lengend Snippet: Effects of DLE and MC on spinal cord IL-31RA in compound 48/80 or chloroquine-injected ICR mice. Spinal cord immunofluorescence stained with antibodies against IL-31RA (green) in mice injected with (A) compound 48/80 and (B) chloroquine (scale bar, 40 µm). (C) Western blotting data showing the expression of IL-31RA in the spinal cord tissue for both compound 48/80 and chloroquine-injected mice. Each bar represents the mean ± SD (n=5). # P<0.05 vs. normal group. * P<0.05 vs. control group. DLE, D. lotus leaf extract; MC, myricitrin; IL-31RA, interleukin-31 receptor A.

Article Snippet: Primary antibodies against GRPR (sc-398549), IL-31RA (sc-515465), p-STAT3 (sc-81523), STAT3 (sc-8019), m-IgGκ BP-HRP (sc-516102) and β-actin (sc-8432) were acquired from Santa Cruz Biotechnology (Dallas, TX, USA).

Techniques: Injection, Immunofluorescence, Staining, Western Blot, Expressing, Control

Journal: Anais brasileiros de dermatologia

Article Title: Methotrexate for refractory adult atopic dermatitis leads to alterations in cutaneous IL-31 and IL-31RA expression.

doi: 10.1016/j.abd.2023.01.002

Figure Lengend Snippet: Figure 1 IL-31RA immunohistochemistry in lesional skin of an Atopic Dermatitis (AD) subject, epidermis (A) and superficial dermis (B).

Article Snippet: Manfrere, N.V. Pereira et al. Table 1 Antibodies that were used for immunohistochemistry Antibody Dilution Code Brand Positive control IL-31 1:6 MAB28241 R&D Systems AD IL-31RA 1:10 AF-2769 R&D Systems AD OSMR 1:50 10982-1-AP Proteintech AD TSLP 1:200 sc-33791 Santa Cruz Prostate Ki-67 1:200 275R-15 Cell Marque Amygdala e t K R m s S e c K 1 c n t ( t 9 6 B n S C t p W R M T s a a d l p I T s n ( d T R T ( M m C D A o i F e t s c S o s C e o C 2 F M a c r e 3 i AD, atopic dermatitis. rates an average value, and calculates the mean epidermal hickness.

Techniques: Immunohistochemistry

Journal: Anais brasileiros de dermatologia

Article Title: Methotrexate for refractory adult atopic dermatitis leads to alterations in cutaneous IL-31 and IL-31RA expression.

doi: 10.1016/j.abd.2023.01.002

Figure Lengend Snippet: Figure 2 Expression of IL-31RA, comparing lesional skin before and after MTX treatment demonstrating a statistically significant change

Article Snippet: Manfrere, N.V. Pereira et al. Table 1 Antibodies that were used for immunohistochemistry Antibody Dilution Code Brand Positive control IL-31 1:6 MAB28241 R&D Systems AD IL-31RA 1:10 AF-2769 R&D Systems AD OSMR 1:50 10982-1-AP Proteintech AD TSLP 1:200 sc-33791 Santa Cruz Prostate Ki-67 1:200 275R-15 Cell Marque Amygdala e t K R m s S e c K 1 c n t ( t 9 6 B n S C t p W R M T s a a d l p I T s n ( d T R T ( M m C D A o i F e t s c S o s C e o C 2 F M a c r e 3 i AD, atopic dermatitis. rates an average value, and calculates the mean epidermal hickness.

Techniques: Expressing

Journal: Anais brasileiros de dermatologia

Article Title: Methotrexate for refractory adult atopic dermatitis leads to alterations in cutaneous IL-31 and IL-31RA expression.

doi: 10.1016/j.abd.2023.01.002

Figure Lengend Snippet: Figure 5 Expression profile of IL-4 (A), IL-6 (B), IL-10 (C), IL-31(D), IL-31RA (E), TNF- (F), IFN- (G), TARC (H) and CCL-22 (I), comparing

Article Snippet: Manfrere, N.V. Pereira et al. Table 1 Antibodies that were used for immunohistochemistry Antibody Dilution Code Brand Positive control IL-31 1:6 MAB28241 R&D Systems AD IL-31RA 1:10 AF-2769 R&D Systems AD OSMR 1:50 10982-1-AP Proteintech AD TSLP 1:200 sc-33791 Santa Cruz Prostate Ki-67 1:200 275R-15 Cell Marque Amygdala e t K R m s S e c K 1 c n t ( t 9 6 B n S C t p W R M T s a a d l p I T s n ( d T R T ( M m C D A o i F e t s c S o s C e o C 2 F M a c r e 3 i AD, atopic dermatitis. rates an average value, and calculates the mean epidermal hickness.

Techniques: Expressing